Ind-Swift Ltd

Ind-Swift Ltd

₹ 25.5 -5.03%
12 Apr 4:05 p.m.
About

Incorporated in 1986, Ind-Swift Ltd deals in manufacturing and exporting of pharmaceutical products

Key Points

Business Overview:[1]
Company has expertise in finished goods dosage, Active Pharmaceutical Ingredients (API’s) and herbal products. Company also diversified into multiple fields viz., Infrastructure, Printing, Packaging & Stationary, Education, and Media Publication with its every unit as an independent profit earning center

  • Market Cap 138 Cr.
  • Current Price 25.5
  • High / Low 31.2 / 7.65
  • Stock P/E
  • Book Value -132
  • Dividend Yield 0.00 %
  • ROCE 8.28 %
  • ROE %
  • Face Value 2.00

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 8.78% over past five years.
  • Promoters have pledged 42.8% of their holding.
  • Earnings include an other income of Rs.78.3 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
105 94 90 97 104 106 95 104 107 106 149 116 103
87 94 80 85 92 96 90 93 89 98 130 105 98
Operating Profit 18 -0 11 13 12 10 5 11 18 8 18 11 4
OPM % 17% -1% 12% 13% 12% 9% 5% 11% 17% 8% 12% 10% 4%
1 5 6 6 4 7 2 1 3 67 6 3 3
Interest 12 13 12 15 14 14 15 15 15 14 15 18 15
Depreciation 8 8 8 8 8 8 7 7 7 7 7 7 7
Profit before tax -1 -17 -3 -5 -6 -5 -15 -11 -1 53 2 -11 -15
Tax % 0% -2% -13% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
-1 -17 -4 -5 -6 -5 -15 -11 -1 53 2 -11 -15
EPS in Rs -0.22 -3.23 -0.66 -0.91 -1.12 -1.01 -2.85 -1.96 -0.19 9.80 0.44 -1.98 -2.76
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Jun 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
1,590 393 570 417 308 263 270 289 330 356 398 411 473
1,494 411 602 487 465 328 262 278 306 315 352 369 431
Operating Profit 97 -18 -32 -70 -157 -65 8 11 23 41 45 42 42
OPM % 6% -4% -6% -17% -51% -25% 3% 4% 7% 12% 11% 10% 9%
24 2 11 2 13 -246 -20 34 22 14 24 72 78
Interest 121 86 77 40 19 16 7 3 29 52 57 60 63
Depreciation 23 18 26 39 36 36 35 34 34 33 32 29 27
Profit before tax -24 -121 -124 -147 -200 -363 -53 8 -17 -29 -20 26 30
Tax % 12% 8% 7% 2% -0% -0% -1% 0% -15% -1% -2% 0%
-21 -111 -116 -145 -200 -364 -54 8 -19 -30 -20 26 30
EPS in Rs -4.55 -24.10 -22.95 -28.83 -39.71 -67.25 -9.99 1.51 -3.53 -5.51 -3.70 4.81 5.50
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 0%
5 Years: 9%
3 Years: 8%
TTM: 15%
Compounded Profit Growth
10 Years: 5%
5 Years: -9%
3 Years: -14%
TTM: 5%
Stock Price CAGR
10 Years: 15%
5 Years: 41%
3 Years: 87%
1 Year: 192%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Jun 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 9 9 10 10 10 11 11 11 11 11 11 11 11
Reserves 295 194 84 -64 -264 -636 -690 -688 -724 -706 -731 -716 -724
Preference Capital 14 14 14 14 14 14 14 14 14 14 14 14
819 971 1,010 1,040 1,047 1,048 1,041 996 1,003 1,008 1,021 978 976
446 233 286 242 268 246 251 279 312 358 331 376 376
Total Liabilities 1,568 1,407 1,390 1,228 1,061 669 613 598 602 672 632 649 639
396 421 440 404 374 342 311 291 270 244 236 216 205
CWIP 49 37 4 4 4 2 0 0 0 13 9 30 35
Investments 46 45 45 45 45 44 44 41 24 70 64 54 54
1,077 905 900 775 638 281 258 267 308 344 323 349 346
Total Assets 1,568 1,407 1,390 1,228 1,061 669 613 598 602 672 632 649 639

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Jun 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
94 -146 103 86 -106 7 1 43 35 83 50 73
-184 -28 -14 -6 -4 -4 -3 -14 -11 -17 -18 -29
99 146 -89 -81 110 -11 -4 -13 -26 -54 -45 -47
Net Cash Flow 9 -28 0 -1 0 -8 -5 16 -3 12 -13 -3

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Jun 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 103 338 282 425 451 151 113 95 104 111 83 93
Inventory Days 98 418 202 117 151 86 108 112 102 123 120 150
Days Payable 90 179 152 155 290 356 426 454 440 454 353 393
Cash Conversion Cycle 112 577 331 387 311 -119 -206 -246 -234 -220 -149 -150
Working Capital Days 101 554 317 325 409 -37 -57 -99 -79 -94 -69 -77
ROCE % 10% -4% -10% -20% -14% -4% -4% 2% 8% 11% 8%

Shareholding Pattern

Numbers in percentages

1 Recently
Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
55.55% 55.55% 55.55% 55.55% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58% 55.58%
1.77% 1.77% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
42.68% 42.68% 44.44% 44.44% 44.42% 44.42% 44.42% 44.40% 44.42% 44.42% 44.42% 44.42%
No. of Shareholders 11,93411,86912,42413,59614,00914,29614,42214,92714,78514,59013,74514,219

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents